cabazitaxel teva
teva b.v. - kabazitakselis - koncentratas infuziniam tirpalui - 10 mg/ml - cabazitaxel
sorafenib accord
accord healthcare s.l.u. - sorafenib tosilate - carcinoma, hepatocellular; carcinoma, renal cell - antinavikiniai vaistai - hepatocellular carcinomasorafenib accord is indicated for the treatment of hepatocellular carcinoma (see section 5. renal cell carcinomasorafenib accord is indicated for the treatment of patients with advanced renal cell carcinoma who have failed prior interferon-alpha or interleukin-2 based therapy or are considered unsuitable for such therapy.
daktarin
lex ano, uab - mikonazolas - valgomasis gelis - 20 mg/g - miconazole
cabazitaxel stada
stada arzneimittel ag - kabazitakselis - koncentratas infuziniam tirpalui - 20 mg/ml - cabazitaxel
herwenda
sandoz gmbh - trastuzumabas - breast neoplasms; stomach neoplasms - antinavikiniai vaistai - treatment of metastatic and early breast cancer and metastatic gastric cancer (mgc).